We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current CABA market cap is 110.95M. The company's latest EPS is USD -1.3846 and P/E is -1.65.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -18.67M | -23.15M | -28.03M | -30.28M | -33.05M |
| Net Income | -16.45M | -20.89M | -25.05M | -27.6M | -30.63M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -18.68M | -33.83M | -46.31M | -54.14M | -74.66M |
| Net Income | -16.94M | -33.34M | -46.29M | -52.98M | -67.68M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 173.29M | 253.65M | 240.46M | 217.42M | 204.41M |
| Total Liabilities | 12.36M | 17.45M | 18.74M | 17.9M | 30.17M |
| Total Equity | 160.92M | 236.2M | 221.72M | 199.52M | 174.24M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 141.47M | 114.72M | 126.34M | 116.97M | 253.65M |
| Total Liabilities | 3.15M | 5.18M | 8.38M | 12.45M | 17.45M |
| Total Equity | 138.32M | 109.54M | 117.96M | 104.52M | 236.2M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -37.1M | -53.55M | -23.99M | -44.78M | -65.1M |
| Investing | -23.59M | -22.45M | -812k | 22.92M | 35.17M |
| Financing | 94.58M | 187.63M | 6.86M | 7.23M | 7.31M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -16.05M | -26.77M | -34.11M | -46.38M | -53.55M |
| Investing | -693k | -7.98M | 6M | -27.22M | -22.45M |
| Financing | 119.93M | -24k | 48.9M | 32.98M | 187.63M |
| Market Cap | 110.95M |
| Price to Earnings Ratio | -1.65 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.58 |
| Price to Book Ratio | 0.47 |
| Dividend Yield | - |
| Shares Outstanding | 48.88M |
| Average Volume (1 week) | 1.36M |
| Average Volume (1 Month) | 3.29M |
| 52 Week Change | -89.92% |
| 52 Week High | 26.35 |
| 52 Week Low | 1.76 |
| Spread (Intraday) | 0.09 (3.85%) |
| Company Name | Cabaletta Bio Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.cabalettabio.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
